When was Cellular Vehicles founded?

Cellular Vehicles was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is Cellular Vehicles located?

Cellular Vehicles is headquartered in San Mateo, United States.

How many employees does Cellular Vehicles have?

As of Sep 30, 2026, the latest employee count at Cellular Vehicles is 7.

Is Cellular Vehicles a funded company?

Cellular Vehicles is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Jun 01, 2024.

When was the latest funding round of Cellular Vehicles?

Cellular Vehicles' latest funding was a $***** Grant (prize money) round on Jun 01, 2024, with participation from 1 investor. Its primary sector is Drug Delivery. In United States, the Drug Delivery sector has seen $257M in funding in 2026 to date.

Where does Cellular Vehicles rank among its competitors?

Cellular Vehicles ranks 40th amongst 114 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laverock Therapeutics, which secured $2.96M in Jun, 2026.

Who are the top competitors of Cellular Vehicles?

Cellular Vehicles' top competitors include Tenaya Therapeutics, Orca Bio and Xeris Pharmaceuticals. Among them, Laverock Therapeutics secured the most recent funding round in June, 2026.

Cellular Vehicles - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of process automation tools for cell-based therapy manufacturing. The company focuses on creating solutions to support the scaling of the cell therapy industry. It aims to facilitate the advancement of cell-based therapies. The company develops tools intended to accelerate the transition to curative treatments.

Website: www.cellularvehicles.com/
Social
Email ID: *****@cellularvehicles.com

Key Metrics

Founded Year

2021

Location

San Mateo, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Jun 01, 2024, $*****

Investors

Boost VC & 1 more

Ranked

40^th among 114 active competitors

Employee Count

7 as on Sep 30, 2026

Similar Companies

Tenaya Therapeutics & 134 more

View Cellular Vehicles' full profile

Cellular Vehicles has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jun 01, 2024 for $*****. 1 investor participated in its latest round. Cellular Vehicles has 2 institutional investors.

Here is the list of recent funding rounds of Cellular Vehicles:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2024	9787791	Grant (prize money)	9131779	7402595	6997313	3332354

Access funding benchmarks and valuations. Sign up today!

View details of Cellular Vehicles's funding rounds and investors

The founders of Cellular Vehicles is Nikhil Joshi.

Here are the details of Cellular Vehicles' key team members:

Nikhil Joshi: Co-Founder of Cellular Vehicles. They are also an angel investor in 1 startup.
Contact Info: 1 email address

View details of Cellular Vehicles's Founder profiles and Board Members

Cellular Vehicles' employee count trend

Cellular Vehicles has 7 employees as of Sep 26. Here is Cellular Vehicles's employee count trend over the years:

Employee count trend for Cellular Vehicles

Uncover Cellular Vehicles' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellular Vehicles include Tenaya Therapeutics, Orca Bio and Xeris Pharmaceuticals. Here is the list of Top 10 competitors of Cellular Vehicles, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tenaya Therapeutics 2016, San Francisco (United States), Public	Developer of regenerative and gene therapeutics for heart failure	$248M	RTW Investments, Fidelity Investments & 7 others	66/100
2nd	Orca Bio 2016, Menlo Park (United States), Series F	Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders	$300M	Lightspeed Venture Partners, Mubadala & 11 others	65/100
3rd	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	62/100
4th	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	62/100
5th	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	61/100
6th	LIfT Biosciences 2016, London (United Kingdom), Series A	Developer of neutrophil-based cell therapies for solid tumors	$20.1M	Downing, Kizoo & 13 others	61/100
7th	Avita Medical 1992, Cambridge (United Kingdom), Public	Regenerative and Respiratory Medicine product company	-	BioScience Managers, Oceania Capital Partners ... & 6 others	61/100
8th	Athira Pharma 2011, Seattle (United States), Public	Developer of drugs for neurodegenerative diseases	$121M	Dolby Family Ventures, Alzheimer's Drug Discovery ... & 23 others	60/100
9th	Tune Therapeutics 2009, Seattle (United States), Series B	Developer of cell and gene therapy by using the epigenomic platform	$222M	New Enterprise Associates, Emerson Collective ... & 9 others	59/100
10th	Laverock Therapeutics 2021, Stevenage (United Kingdom), Seed	Developer of next generation of programmable cell therapies	$66.8M	Calculus Capital, Shin Shin International Holdings ... & 31 others	56/100
40th	Cellular Vehicles 2021, San Mateo (United States), Funding Raised	Developer of process automation tools for cell-based therapy manufacturing	-	Boost VC, HHS	35/100